SpaceX Nears a Major Milestone Within 15 Days, and Investors Should Pay Attention

SpaceX’s Starship (V3) has completed 12 flight tests and a 13th launch is expected within ~15 days (mid-July), which could improve launch economics (targeting up to 95% lower costs vs. Falcon 9). However, profitability remains weak with a 2025 net loss of $4.9B vs. $791M net income in 2024, and Starlink ARPU fell to $66 in Q1 2026 from $86 in Q1 2025 (down from $99 in 2023), implying potential margin pressure. With Starlink pricing headwinds and regulatory exposure (U.S. federal contracts at ~20% of revenue), the article argues the stock is high-risk and investors should wait for a pullback.

Analysis

The key mechanism is not “space is hot,” it is whether launch cost compression meaningfully lifts unit economics fast enough to offset softer monetization in the core connectivity franchise. If Starship improves on cadence and reliability, the biggest beneficiaries may actually be downstream users of cheaper lift—operators that need heavy payload deployment or frequent replenishment—while the launch incumbent itself only wins if utilization ramps faster than price competition. That creates a subtle risk: the same technical success that validates the platform can also lower barriers for rivals such as AMZN’s Kuiper ecosystem, ASTS, and other LEO-heavy models.

Near term, the stock is likely to trade more on binary test outcomes than fundamentals, but the true catalyst window is 1–3 quarters, when repeated monthly flights either prove operational tempo or expose a “great demo, weak business” gap. The market will likely look through one successful test if ARPU continues to drift and the company is still funding growth with external capital or contract concentration risk remains high. The biggest reversal risk is a sequence of clean launches paired with evidence that pricing can stabilize; without that, any pop is vulnerable to multiple compression once the event premium fades.

Contrarian view: consensus may be overrating launch economics and underrating demand elasticity. Cheaper launch expands TAM, but it also invites more supply into LEO and makes the competitive response cheaper for others, so margin capture may diffuse rather than concentrate. The more actionable expression is to fade exuberance in SPCX after event-driven spikes and own the beneficiaries of cheaper access to orbit, not the company whose economics are still tied to proving that cheaper launches can be monetized before they commoditize the stack.

Key Decisions for Investors

• Do not initiate a fresh long in SPCX ahead of the next Starship milestone; wait for the event and 48-72 hours of price discovery, because the first move is likely sentiment-driven rather than fundamental. If the stock rallies >10-15% on a successful test without an ARPU inflection, use strength to reduce exposure or fade via a short-dated put spread.
• If SPCX trades materially higher on test success, consider a 1-3 month bearish options structure rather than outright short stock: buy an at-the-money put and sell a lower strike put to define risk while expressing the view that launch validation does not fix monetization. Falsify this thesis if monthly cadence accelerates and management shows clear pricing stabilization or margin expansion in the next two quarters.
• Relative-value expression: long ASTS / short RKLB on a successful Starship execution path, because lower launch costs should benefit large-satellite deployment and constellation economics more than it helps a launch competitor with higher direct exposure to launch pricing pressure. Best entered after the next successful flight when the market starts pricing lower orbital access as a structural rather than one-off improvement.
• Watch item rather than trade: if federal contract concentration becomes an active political issue or procurement delays emerge, expect a second-leg de-rating in SPCX over 6-18 months. A clean rebuttal would be a renewed government award cycle or a visible reduction in revenue concentration below the current level.